{"id":"https://openalex.org/W1565699562","doi":"https://doi.org/10.1111/j.1464-5491.2012.03652.x","title":"Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti\u2010diabetic medication: a follow\u2010up study","display_name":"Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti\u2010diabetic medication: a follow\u2010up study","alternate_titles":[],"publication_year":2012,"publication_date":"2012-03-14","ids":{"openalex":"https://openalex.org/W1565699562","doi":"https://doi.org/10.1111/j.1464-5491.2012.03652.x","mag":"1565699562","pmid":"https://pubmed.ncbi.nlm.nih.gov/22416857","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3505380"},"language":"en","primary_location":{"id":"doi:10.1111/j.1464-5491.2012.03652.x","doi":"https://doi.org/10.1111/j.1464-5491.2012.03652.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2012.03652.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1565699562"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3505380/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073093450","display_name":"Mad\u00e9 Wenten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"M. Wenten","raw_affiliation_strings":["Amylin Pharmaceuticals Inc., San Diego, CA, USA. made.wenten@amylin.com","Amylin Pharmaceuticals, Inc, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals Inc., San Diego, CA, USA. made.wenten@amylin.com","institution_ids":[]},{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113496308","display_name":"J. A. Gaebler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. A. Gaebler","raw_affiliation_strings":["Amylin Pharmaceuticals Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101651441","display_name":"Mohamed A. Hussein","orcid":"https://orcid.org/0000-0002-6138-7021","observed_orcids":["https://orcid.org/0000-0002-6138-7021"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Hussein","raw_affiliation_strings":["IMS Health Incorporated, Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health Incorporated, Watertown, MA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110154128","display_name":"E.M. Pelletier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. M. Pelletier","raw_affiliation_strings":["IMS Health Incorporated, Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health Incorporated, Watertown, MA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. B. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. B. Smith","raw_affiliation_strings":["IMS Health Incorporated, Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health Incorporated, Watertown, MA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016245789","display_name":"Prafulla G Girase","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Girase","raw_affiliation_strings":["IMS Health Incorporated, Watertown, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health Incorporated, Watertown, MA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059791517","display_name":"Rebecca A. Noel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. A. Noel","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. K. Braun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. K. Braun","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085931384","display_name":"Gary Bloomgren","orcid":"https://orcid.org/0000-0002-5519-7256","observed_orcids":["https://orcid.org/0000-0002-5519-7256"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. L. Bloomgren","raw_affiliation_strings":["Amylin Pharmaceuticals Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals Inc., San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073093450"],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":10.5034,"has_fulltext":true,"cited_by_count":77,"citation_normalized_percentile":{"value":0.98847231,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"29","issue":"11","first_page":"1412","last_page":"1418"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5820000171661377,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.4092000126838684,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-pancreatitis","display_name":"acute pancreatitis","score":0.8980000019073486},{"id":"https://openalex.org/keywords/exenatide-twice-daily","display_name":"exenatide twice daily","score":0.9760000109672546},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8799999952316284},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8259999752044678},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.5870000123977661},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.453000009059906},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.5329999923706055},{"id":"https://openalex.org/keywords/health-insurance-claims-data","display_name":"health insurance claims data","score":0.6679999828338623},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9918322563171387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9559749960899353},{"id":"https://openalex.org/C2776670229","wikidata":"https://www.wikidata.org/wiki/Q854573","display_name":"Acute pancreatitis","level":2,"score":0.8406368494033813},{"id":"https://openalex.org/C2775967933","wikidata":"https://www.wikidata.org/wiki/Q1527888","display_name":"Pancreatitis","level":2,"score":0.6491820812225342},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5742047429084778},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.504313588142395},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.4701167643070221},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4665287137031555},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.24197500944137573},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.12463697791099548}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007231","descriptor_name":"Infant, Newborn","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007348","descriptor_name":"Insurance, Health","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D038801","descriptor_name":"International Classification of Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1464-5491.2012.03652.x","doi":"https://doi.org/10.1111/j.1464-5491.2012.03652.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1464-5491.2012.03652.x","pdf_url":null,"source":{"id":"https://openalex.org/S72944096","display_name":"Diabetic Medicine","issn_l":"0742-3071","issn":["0742-3071","1096-9136","1464-5491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3505380","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3505380/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3505380/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabet Med","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:2513660","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3505380","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:22416857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22416857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetic medicine : a journal of the British Diabetic Association","raw_type":"Comparative Study"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3505380","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3505380/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3505380/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabet Med","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1565699562.pdf","grobid_xml":"https://content.openalex.org/works/W1565699562.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1939311003","https://openalex.org/W1970638723","https://openalex.org/W1977598357","https://openalex.org/W2007644870","https://openalex.org/W2024440860","https://openalex.org/W2024569808","https://openalex.org/W2033088588","https://openalex.org/W2033805981","https://openalex.org/W2040113464","https://openalex.org/W2050984323","https://openalex.org/W2057913111","https://openalex.org/W2068253759","https://openalex.org/W2069392152","https://openalex.org/W2070710390","https://openalex.org/W2092014168","https://openalex.org/W2092361523","https://openalex.org/W2098008729","https://openalex.org/W2110573974","https://openalex.org/W2116926841","https://openalex.org/W2121690051","https://openalex.org/W2122532950","https://openalex.org/W2140276611","https://openalex.org/W2150291618","https://openalex.org/W2153323738","https://openalex.org/W2164535707","https://openalex.org/W2186928376","https://openalex.org/W4210998956"],"related_works":["https://openalex.org/W2094195067","https://openalex.org/W2004541371","https://openalex.org/W2164535707","https://openalex.org/W1970638723","https://openalex.org/W2066987382","https://openalex.org/W2943931901","https://openalex.org/W2022607643","https://openalex.org/W2398680131","https://openalex.org/W2739048242"],"abstract_inverted_index":{"AIMS:":[0],"Previously,":[1],"a":[2,40,81,86,89],"retrospective":[3],"cohort":[4],"study":[5,31,232],"found":[6,215],"no":[7,216],"increased":[8,217,245],"risk":[9,218,246],"of":[10,18,25,39,104,116,120,161,172,184,219,227,247,264],"acute":[11,34,105,142,189,220,248],"pancreatitis":[12,84,106,221,249],"with":[13,23,36,55,112,170,188,194,222,243,251],"current":[14],"or":[15,94],"recent":[16,210],"use":[17,24,38,183],"exenatide":[19,51,138,151,162,195,223,237],"twice":[20,52,139,152,163,196,224,238],"daily":[21,53,140,153,164,197,239],"compared":[22,54,169,250],"other":[26,59,173,254],"anti-diabetic":[27,60,91,158,174,255],"drugs.":[28],"This":[29,231],"follow-up":[30],"investigated":[32],"incident":[33],"pancreatitis,":[35,190],"the":[37,123,135,191],"different":[41],"data":[42],"source":[43],"and":[44,85,141,154,182,211,268],"analytic":[45],"method,":[46],"in":[47,122,262],"patients":[48,56,73,111],"exposed":[49,57],"to":[50,58,99,133,236,253],"medications.":[61,175,256],"METHODS:":[62],"A":[63,126,204],"large":[64],"US":[65],"health":[66],"insurance":[67],"claims":[68],"database":[69],"was":[70,131,199,240],"used.":[71],"Eligible":[72],"had":[74,165],"\u2265":[75],"9":[76,118],"months":[77],"continuous":[78],"enrollment":[79],"without":[80],"claim":[82,87],"for":[83,88,178],"new":[90],"medication":[92,185,213],"on":[93],"after":[95],"1":[96],"June":[97],"2005":[98],"31":[100],"March":[101],"2009.":[102],"Cases":[103],"were":[107],"defined":[108],"as":[109],"hospitalized":[110],"an":[113,244],"Internation":[114],"Classification":[115],"Disease":[117],"code":[119],"577.0":[121],"primary":[124],"position.":[125],"discrete":[127],"time":[128],"survival":[129],"model":[130],"used":[132],"evaluate":[134],"relationship":[136],"between":[137],"pancreatitis.":[143],"RESULTS:":[144],"Of":[145],"482,034":[146],"eligible":[147],"patients,":[148],"24,237":[149],"initiated":[150,156],"457,797":[155],"another":[157],"medication.":[159],"Initiators":[160],"more":[166],"severe":[167],"diabetes":[168],"initiators":[171],"After":[176],"adjustments":[177],"propensity":[179],"score,":[180],"insulin":[181],"potentially":[186],"associated":[187,242],"odds":[192],"ratio":[193],"exposure":[198,214,228,235,252],"0.95":[200],"(95%":[201],"CI":[202],"0.65-1.38).":[203],"secondary":[205],"analysis":[206],"that":[207,234],"examined":[208],"current,":[209],"past":[212],"daily,":[225],"regardless":[226],"category.":[229],"CONCLUSION:":[230],"indicates":[233],"not":[241],"These":[257],"results":[258],"should":[259],"be":[260],"interpreted":[261],"light":[263],"potential":[265],"residual":[266],"confounding":[267],"unknown":[269],"biases.":[270]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1565699562","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":22},{"year":2013,"cited_by_count":19},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
